|Bid||56.630 x 200|
|Ask||56.660 x 300|
|Day's Range||56.140 - 56.940|
|52 Week Range||40.510 - 57.610|
|PE Ratio (TTM)||69.16|
|Earnings Date||Apr 24, 2018 - Apr 30, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||56.42|
Integra LifeSciences's (IART) solid Q4 revenue growth was primarily driven by high organic revenues and better-than-expected performance by the recently-acquired businesses.
NEW YORK, Feb. 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Insteel ...
On a per-share basis, the Plainsboro, New Jersey-based company said it had profit of 56 cents. Earnings, adjusted for one-time gains and costs, were 64 cents per share. The results exceeded Wall Street ...
NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Integra LifeSciences Holdings Corporation (NASDAQ: IART ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, ...
PLAINSBORO, N.J., Feb. 27, 2018-- Integra LifeSciences Holdings Corporation today reported financial results for the fourth quarter and full-year ended December 31, 2017.. The Company completed the acquisition ...
PLAINSBORO, N.J., Feb. 26, 2018-- Integra LifeSciences Holdings Corporation today announced the appointment of Sravan Emany as vice president, treasurer and investor relations. Emany will be a member of ...
Integra LifeSciences (IART) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
PLAINSBORO, N.J., Feb. 21, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, will present at the following healthcare conferences in March:. On Monday, March ...
Integra LifeSciences (IART) witnesses strong global sales within specialty surgical driven by strength in door repair and tissue ablation franchises in Asia Pacific and Europe.
PLAINSBORO, N.J., Feb. 01, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, will release fourth quarter and full year 2017 financial results on Tuesday, February ...
This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on January 11. Over the last one-month, outflows of investor capital in ETFs holding IART totaled $5.47 billion.
Integra LifeSciences (IART) sees strong organic growth in the company's Specialty Surgical Solutions as well as Orthopedics and Tissue Technologies businesses.
This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on December 27. Index (PMI) data, output in the Healthcare sector is rising.
Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the company’ s previous implied guidance range of $345 million to $355 million; Organic revenue ...
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Integra LifeSciences Holdings Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)